Combination of CAR‑T cell therapy and radiotherapy: Opportunities and challenges in solid tumors (Review)

Chimeric antigen receptor (CAR) T cell therapy has emerged as a new and breakthrough cancer immunotherapy. Although CAR-T cell therapy has made significant progress clinically in patients with refractory or drug-resistant hematological malignancies, there are numerous challenges in its application t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Liqiang, Li, Yi, Muluh, Tobias Achu, Wang, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236127/
https://www.ncbi.nlm.nih.gov/pubmed/37274466
http://dx.doi.org/10.3892/ol.2023.13867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236127/
https://www.ncbi.nlm.nih.gov/pubmed/37274466
http://dx.doi.org/10.3892/ol.2023.13867

Ejemplares similares